Future Pharmaceutical Innovation Requires Patients To Be Placed Right At The Centre Unless points of contention between the pharmaceutical industry and the medical profession are resolved satisfactorily, future advances in the quality of patient care may be put at risk. This is the conclusion reached by a multi-sector working party convened by the Royal College of Physicians. The group's report, Innovating for health: Patients, physicians, the pharmaceutical industry and the NHS identifies a number of critical threats to clinical research in the UK.
Source: www.medicalnewstoday.comNew FDA Guidelines Easing Drugmakers' Promotion Of Off-Label Uses Met With Endorsements, Criticisms McClatchy/Philadelphia Inquirer on Monday examined guidelines released by
FDA in the last week of former President George W. Bush's term that make it easier for drug manufacturers to promote "off-label" uses for
prescription drugs.
Source: www.medicalnewstoday.com
# posted by Network @ 3:03 PM
